98 related articles for article (PubMed ID: 11509170)
1. Is fluvoxamine safe and effective for treating anxiety disorders in children?
Burke JM; Baker RC
J Fam Pract; 2001 Aug; 50(8):719. PubMed ID: 11509170
[No Abstract] [Full Text] [Related]
2. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis.
Uthman OA; Abdulmalik J
Curr Med Res Opin; 2010 Jan; 26(1):53-9. PubMed ID: 19905879
[TBL] [Abstract][Full Text] [Related]
3. [Evidence-based medicine in therapy of anxiety disorders].
Bandelow B; Engel K; Wedekind D
MMW Fortschr Med; 2009 Mar; 151(13):89-91. PubMed ID: 19504830
[No Abstract] [Full Text] [Related]
4. Are antibiotics effective in the treatment of acute sinusitis in children and adolescents?
Henderson J; Stevermer JJ
J Fam Pract; 2001 Aug; 50(8):717. PubMed ID: 11509168
[No Abstract] [Full Text] [Related]
5. Compulsive buying and binge eating disorder--a case vignettes.
Marcinko D; Bolanca M; Rudan V
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1542-4. PubMed ID: 16815617
[TBL] [Abstract][Full Text] [Related]
6. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.
de Jongh R; Groenink L; van Der Gugten J; Olivier B
Psychopharmacology (Berl); 2002 Jan; 159(2):176-80. PubMed ID: 11862346
[TBL] [Abstract][Full Text] [Related]
7. Myth of reincarnation: a challenge for mental health profession.
Gadit AA
J Med Ethics; 2009 Feb; 35(2):91. PubMed ID: 19181879
[TBL] [Abstract][Full Text] [Related]
8. A case of pathological gambling--its features and mangement.
Lim KD
Singapore Med J; 2001 May; 42(5):217-9. PubMed ID: 11513060
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm.
Miyamoto J; Tsuji M; Takeda H; Ohzeki M; Nawa H; Matsumiya T
Eur J Pharmacol; 2004 Nov; 504(1-2):97-103. PubMed ID: 15507225
[TBL] [Abstract][Full Text] [Related]
10. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
Pasquini M; Berardelli I
Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
Baldwin DS; Anderson IM; Nutt DJ; Bandelow B; Bond A; Davidson JR; den Boer JA; Fineberg NA; Knapp M; Scott J; Wittchen HU;
J Psychopharmacol; 2005 Nov; 19(6):567-96. PubMed ID: 16272179
[TBL] [Abstract][Full Text] [Related]
12. Treatment of anxiety disorders in the Finnish general population.
Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
[TBL] [Abstract][Full Text] [Related]
13. Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders.
Bereza BG; Machado M; Einarson TR
Ann Pharmacother; 2008 Oct; 42(10):1402-9. PubMed ID: 18728102
[TBL] [Abstract][Full Text] [Related]
14. Treating anxiety in elderly patients.
Jenike MA
Geriatrics; 1983 Oct; 38(10):115-9. PubMed ID: 6137438
[No Abstract] [Full Text] [Related]
15. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.
Connolly SD; Bernstein GA;
J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):267-83. PubMed ID: 17242630
[TBL] [Abstract][Full Text] [Related]
16. [Therapy for mood disorders].
Nomura S
Seishin Shinkeigaku Zasshi; 2006; 108(11):1244-8. PubMed ID: 17375458
[No Abstract] [Full Text] [Related]
17. Chronic anxiolytic treatment: benefit and risk.
Marks J
Adv Biochem Psychopharmacol; 1985; 40():173-83. PubMed ID: 2862763
[No Abstract] [Full Text] [Related]
18. Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines.
Moeller KE; Barnes BJ; Stanley KM; Worrall CL; Lunsford SL; Simpson KN; Miller JG; Spencer AP
Pharmacotherapy; 2006 Mar; 26(3):445-6. PubMed ID: 16503729
[No Abstract] [Full Text] [Related]
19. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Lee SH; Ahn SC; Lee YJ; Choi TK; Yook KH; Suh SY
J Psychosom Res; 2007 Feb; 62(2):189-95. PubMed ID: 17270577
[TBL] [Abstract][Full Text] [Related]
20. An overview of evidence-based psychotherapy for children and adolescents.
Rzepski B; Jarasek N
Conn Med; 2005 Oct; 69(9):553-9. PubMed ID: 16270793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
